These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 828757)

  • 21. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
    Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
    Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
    [No Abstract]   [Full Text] [Related]  

  • 22. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs.
    Nicoletti P; Mazzei T; Lamanna S
    G Batteriol Virol Immunol; 1981; 74(1-6):3-7. PubMed ID: 6458526
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tobramycin. In vitro action of a new aminoside. Comparative study in 2 hospital centers].
    Morel C; Freymuth F; Nevot P; Kazmierczak A; Philippon A; Paul G
    Nouv Presse Med; 1973 May; 2(18):1219-23. PubMed ID: 4197620
    [No Abstract]   [Full Text] [Related]  

  • 27. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic sensitivity, serology and typing by pyocine in 154 cultures of Pseudomonas aeruginosa (author's transl)].
    Cantos de la Casa A; García Curiel A; Gómez Fernández MV; Arroyo Trillo A; Díaz Sánchez JA; Dueñas P
    Med Clin (Barc); 1980 Jul; 75(3):104-8. PubMed ID: 6772890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug selection for antimicrobial susceptibility testing (author's transl)].
    Kobayashi A
    Rinsho Byori; 1979 May; 27(5):385-92. PubMed ID: 114698
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibacterial activity of tobramycin on Pseudomonas aeruginosa].
    Fleurette J; Flandrois JP
    Nouv Presse Med; 1974 Apr; 3(0):40-2. PubMed ID: 4209337
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.
    Davidson S; Lipshitz M; Bogokowski B; Rubinstein E
    Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R; Fish DN; Obritsch MD; MacLaren R
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on in vitro resistance of Pseudomonas aeruginosa to tobramycin.
    Athar MA; Knez E
    Can J Public Health; 1976; 67(3):252-5. PubMed ID: 819123
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O; Giwercman B; Pedersen SS; Høiby N
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative study of cephotaxime and other antimicrobial agents in relationship to Pseudomonas aeruginosa (author's transl)].
    García Martos P; Rodríguez Sarmiento MT; García Herruzo J; Fernández Gutiérrez del Alamo C; Romera Cano MA; Martínez País Romaní R
    Med Clin (Barc); 1982 Feb; 78(4):148-51. PubMed ID: 6279982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.